Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(577)
•••
Comment by Quattro74on May 12, 2020 10:40am
76 Views
Post# 31016562

RE:Makes Sense

RE:Makes Sense
Well I guess Covid has put a damper on any patient data/news for a bit. So we get NRs like this to warp our brains? Ugh! I think this is fine since these warrants are in friendly hands, TLT probably expected to be high enuf in SP to bring this $$ ito the coffers, cuz of Covid they are extending this, probably don't need 2 years but WTH. At least this $$ will be in their long term plans still.

investclub wrote: When this last 30 cent raise occured some here complained that warrants at 35 cents for 5 years was way overboard and gave up too much to those able to get in! Next some here complained when TLT awarded itself 25 cent share options for 5 years even though almost all listed companies do that also! Now some are complaining that 2 year warrants have been extended on those 30 cent warrants by 2 years which are held by a few here  ... this appears to award equal opportunity to those as to insider option holders and to what the financial institutions received. Some here complain when others get and now complain when average Joe get! Again out comes no logic  ...  please wait to you know why before pointing you fingers ....

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities